Lifeward Ltd.

ReWalk is a medical device company that designs, develops, and commercializes solutions for physical rehabilitation and recovery. The company's initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices, referred to as SCI Products, for individuals with spinal cord injury. These robotic exoskeletons use patented tilt-sensor technology, an onboard computer, and motion sensors to power motorized legs, enabling individuals with paraplegia to stand and walk. In March 2023, ReWalk received 510(k) clearance from the U.S. FDA for the ReWalk Personal Exoskeleton with stair and curb functionality, allowing U.S. users to navigate stairs and curbs. This feature has been available in Europe since initial CE Clearance, supported by real-world data from 47 European users over seven years, involving over 18,000 stair steps. In March 2025, the company received 510(k) clearance for the ReWalk 7 Personal Exoskeleton device, a next-generation model. ReWalk has also expanded its product offerings beyond SCI Products, including the ReStore Exo-Suit device, which began commercialization in June 2019. The ReStore is a powered, lightweight soft exo-suit designed for the rehabilitation of individuals with lower limb disabilities due to stroke. Sales of the ReStore device in the European Union ceased in May 2024.